Oncology innovation is outpacing access systems, warns Belgian cancer expert

EURACTIV - Cancer innovation is advancing at unprecedented speed, but Belgium's access systems are struggling to keep up, risking delays in patient access to personalised, biomarker-driven treatments, according to Koen Van Impe (KVI), CEO of the Belgian Cancer Foundation. Read more

Koen van Impe, CEO of the Belgian Cancer Foundation